MEC/09/06/063 Approve Cephalon Bright Study Dr Peter Ganly Intervention Epigenetics and genetics of MEC/09/07/068 Approve Professor Ian Morison Intervention myelodysplasia. randomised double double dummy MEC/09/07/074 Approve carbidopa levodopa intestinal gel S Prof Tim Anderson Intervention 187.3.002 Open Label, 12 Months safety and Invalid efficacy study of levodopa-intestinal gel in MEC/09/07/075 Prof Tim Anderson Intervention Application levodopa-responsive Parkinson's disease subjects, protocol # S 187.3.003 Investigation of genetic susceptibility alleles in Ankylosing spondylitis and the Auckland District MEC/09/08/084 Approve Dr Simon Stebbings Intervention prevalence and severity of clinical Health Board features Professor Anthony MEC/09/08/094 Approve Structure of glaucoma surgery blebs Intervention Molteno The New Zealand Institute for Rare Professor Michael MEC/09/09/098 Approve Intervention Disease Research Human Tissue Bank Eccles Self-care in New Zealand: Patient and MEC/09/10/117 Approve Mrs Mandy Wilkinson Intervention nurse perspectives MEC/09/65/EXP Approve Effects of cancer control activities Assoc. Prof. Brian Cox Intervention Invalid Assessment of the investigational drug MEC/10/03/026 Dr Wynne Intervention Application AMG 139, MEC/10/064/EXP Approve Life, Health and Activities Survey Assoc. Prof. Brian Cox Intervention MEC/10/073/EXP Approve AS Database Dr Macintyre Intervention Dialysis outcomes in those aged >65 Professor Robert MEC/10/08/084 Approve Intervention years Walker Developing biomarkers for a predictive MEC/10/09/086 Approve Prof Robert Knight Intervention test of Alzheimer's disease MEC/10/09/090A Approve Apremilast Palace 1 study. Dr Daniel Ching Intervention MEC/10/09/090B Approve Apremilast Palace 4 study. Dr Daniel Ching Intervention Audit of the use of antipsychotics in MEC/10/102/EXP Approve Dr June Tordoff Intervention dementia units in New Zealand
MEC/09/06/063 Approve Cephalon Bright Study Dr Peter Ganly Intervention MEC/09/07/068 Approve Epigenetics and genetics of myelodysplasia. Professor Ian Morison Intervention MEC/09/07/074 Approve randomised double double dummy carbidopa levodopa intestinal gel S 187.3.002 Prof Tim Anderson Intervention MEC/09/07/075 Invalid Application Open Label, 12 Months safety and efficacy study of levodopa-intestinal gel in levodopa-responsive Parkinson's disease subjects, protocol # S 187.3.003 Prof Tim Anderson Intervention MEC/09/08/084 Approve Investigation of genetic susceptibility alleles in Ankylosing spondylitis and the prevalence and severity of clinical features Dr Simon Stebbings Auckland District Health Board Intervention MEC/09/08/094 Approve Structure of glaucoma surgery blebs Professor Anthony Molteno Intervention MEC/09/09/098 Approve The New Zealand Institute for Rare Disease Research Human Tissue Bank Professor Michael Eccles Intervention MEC/09/10/117 Approve Self-care in New Zealand: Patient and nurse perspectives Mrs Mandy Wilkinson Intervention MEC/09/65/EXP Approve Effects of cancer control activities Assoc. Prof. Brian Cox Intervention MEC/10/03/026 Invalid Application Assessment of the investigational drug AMG 139, Dr Wynne Intervention MEC/10/064/EXP Approve Life, Health and Activities Survey Assoc. Prof. Brian Cox Intervention MEC/10/073/EXP Approve AS Database Dr Macintyre Intervention MEC/10/08/084 Approve Dialysis outcomes in those aged >65 years Professor Robert Walker Intervention MEC/10/09/086 Approve Developing biomarkers for a predictive test of Alzheimer's disease Prof Robert Knight Intervention MEC/10/09/090A Approve Apremilast Palace 1 study. Dr Daniel Ching Intervention MEC/10/09/090B Approve Apremilast Palace 4 study. Dr Daniel Ching Intervention MEC/10/102/EXP Approve Audit of the use of antipsychotics in dementia units in New Zealand Dr June Tordoff Intervention
southern-ethics-committee-annual-report-2013.docx